ArticleBMC pulmonary medicine2021
Pulmonary cavitation: an under-recognized late complication of severe COVID-19 lung disease.
Article in BMC pulmonary medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
38 citing papers in PubMed, 1 synthesis or guideline pooled it, 60 citations in OpenAlex.
- Air leak with COVID-19 - A meta-summary.Asian cardiovascular & thoracic annals · 2022Pooled it
- Pulmonary Cavitation as a Late and Self-Limited Complication of COVID-19 Pneumonia: A Case Report.Cureus · 2025Article
- An Observational Cohort Study of Bronchoalveolar Lavage Fluid Galactomannan andOpen forum infectious diseases · 2025Article
- Impact of underlying diseases and complications on COVID-19 mortality in South Korea: analysis of national health insurance service data.Archives of public health = Archives belges de sante publique · 2025Article
- Evaluating the Cavitary Lung Lesions on CT Scan of COVID-19 Patients: A Retrospective Study.Journal of community hospital internal medicine perspectives · 2024Article
- COVID-19 associated lung cavitary lesions: A case series.Caspian journal of internal medicine · 2024Article
- Article
- The impact of COVID-19 on TB in Iran: An illustrative study.Journal of clinical tuberculosis and other mycobacterial diseases · 2023Article
- COVID-19 and Cavitary Lesion in Lung.Cureus · 2023Article
- Surgical therapy for major lung parenchymal damage from late coronavirus disease complication: case report and literature review.AME case reports · 2023Article
- Cavitary lung lesion as sequelae of mild COVID-19 in a patient with HIV.Clinical infection in practice · 2023Article
- Predictors of severe COVID-19 among healthcare workers in Sabah, Malaysia.BMC health services research · 2022Article
- Pulmonary cavitation in follow-up COVID 2019 cases: An etiological perspective.Medical journal, Armed Forces India · 2022Article
- Co-Infections and Superinfections in COVID-19 Critically Ill Patients Are Associated with CT Imaging Abnormalities and the Worst Outcomes.Diagnostics (Basel, Switzerland) · 2022Article
- COVID-19 infection and nocardiosis causing the death of an adolescent with cystic fibrosis.Pediatric pulmonology · 2022Article
- Haemoptysis in COVID-19 pneumonia.Breathe (Sheffield, England) · 2022Article
- Post-COVID-19 Pulmonary Infarction Complicated by Spontaneous Pneumothorax: A Case Report.Cureus · 2022Article
- [Pulmonary cavitations, late complication of COVID-19].Anales del sistema sanitario de Navarra · 2022Article
- Acinetobacter: A Rare Cause of Rapid Development of Cavitary Lung Lesion Following COVID-19 Infection.Cureus · 2022Article
- Post-COVID-19 pulmonary cavitation and tension pneumothorax in a non-ventilated patient.Journal of family medicine and primary care · 2022Article
Corrections and comments
- Commented on by
Authors and funding
9 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPulmonary radiological findings of the novel coronavirus disease 2019 (COVID-19) have been well documented and range from scattered ground-glass infiltrates in milder cases to confluent ground-glass change, dense consolidation, and crazy paving in the critically ill. However, lung cavitation has not been commonly described in these patients. The objective of this study was to assess the incidence of pulmonary cavitation in patients with COVID-19 and describe its characteristics and evolution.
methodsWe conducted a retrospective review of all patients admitted to our institution with COVID-19 and reviewed electronic medical records and imaging to identify patients who developed pulmonary cavitation.
resultsTwelve out of 689 (1.7%) patients admitted to our institution with COVID-19 developed pulmonary cavitation, comprising 3.3% (n = 12/359) of patients who developed COVID-19 pneumonia, and 11% (n = 12/110) of those admitted to the intensive care unit. We describe the imaging characteristics of the cavitation and present the clinical, pharmacological, laboratory, and microbiological parameters for these patients. In this cohort six patients have died, and six discharged home.
conclusionCavitary lung disease in patients with severe COVID-19 disease is not uncommon, and is associated with a high level of morbidity and mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.